Robin Mansukhani
FounderCEO and Co-Founder at Deciduous Therapeutics
San Francisco, California, United States
FoundedDeciduous Therapeutics
About
Robin Mansukhani is CEO and co-founder of Deciduous Therapeutics, a venture-backed company developing immunotherapies for age-related diseases, and previously co-founded and led Alzeca Biosciences, a CNS diagnostic imaging company. He has advised early-stage biotechs including Therini Bio and Reservoir Neurosciences, and earlier worked in venture capital at The Maple Fund and investment banking at Axiom Capital. Mansukhani co-founded BlueStamp Engineering, served a term in AmeriCorps, and holds a B.S. in Biochemistry from Case Western Reserve University.
CEO and Co-Founder at Deciduous Therapeutics
Intro paths
In turn, Robin can intro founders to Deciduous Therapeutics's investors below.
Deciduous Therapeutics's investors Β· 8
Co-founders at Deciduous Therapeutics

Experience
- Deciduous TherapeuticsCEOcurrent2018 β presentSan Francisco Bay Area
- BlueStamp EngineeringCo-Founder, Board Membercurrent2011 β presentPalo Alto, San Francisco, and NYC
- Reservoir NeuroscienceAdvisor2019 β 2021San Francisco Bay Area
- Therini Bio, Inc. (formerly MedaRed, Inc.)Advisor2018San Francisco Bay Area
- Alzeca BiosciencesCo-Founder, CEO2011 β 2017San Francisco Bay Area
- Cense BiosciencesVice President, Founder2008 β 2011
- LivinGreen MaterialsVice President, Founder2009 β 2010
- New York UniversityEntrepreneur in Residence2010
- Axiom Capital ManagementEarly Stage Ventures2007 β 2009
- Azano PharmaceuticalsCo-Founder2006
- The Maple FundAssociate2005 β 2006
Skills & more
+6 more
BiotechnologyBusiness DevelopmentLife SciencesManagementStrategyPharmaceutical IndustryFrom Robin's professional profile.
Frequently asked questions
- Who is Robin Mansukhani?
- Robin Mansukhani is CEO and co-founder of Deciduous Therapeutics, a venture-backed company developing immunotherapies for age-related diseases, and previously co-founded and led Alzeca Biosciences, a CNS diagnostic imaging company. He has advised early-stage biotechs including Therini Bio and Reservoir Neurosciences, and earlier worked in venture capital at The Maple Fund and investment banking at Axiom Capital. Mansukhani co-founded BlueStamp Engineering, served a term in AmeriCorps, and holds a B.S. in Biochemistry from Case Western Reserve University.
- Where does Robin Mansukhani work?
- Robin Mansukhani is CEO and Co-Founder of Deciduous Therapeutics.
- What companies did Robin Mansukhani found?
- Robin Mansukhani founded Deciduous Therapeutics.
- Where did Robin Mansukhani go to school?
- Robin Mansukhani studied at Case Western Reserve University (B.S., Biochemistry).
Founder mafias
Case Western Reserve University mafia23
Also came through, then founded or led a company.
+ 16 more
Same school
Also attended Case Western Reserve University75
+ 69 more
Shared employers
Also worked at Deciduous Therapeutics2
Also worked at BlueStamp Engineering1
Also worked at Therini Bio, Inc. (formerly MedaRed, Inc.)3
Also worked at New York University116
+ 110 more

























